Unhedged cover image

Novo Nordisk, Eli Lilly and the GLP-1 economy

Unhedged

00:00

The Cultural Shift of GLP-1 Medications

This chapter explores the societal impacts of GLP-1 medications on fitness and weight loss perceptions, as well as shifts in consumer behavior among shoppers and retail leaders. It also analyzes the economics of these drugs, including their high costs, implications for insurance coverage, and insights from the Congressional Budget Office on their cost-effectiveness.

Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner